Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| ARBUTUS BIOPHARMA | 7 | - | +4,21 % | ||
| BIONTECH | 5 | 13 | +0,42 % | ||
| ALLOGENE THERAPEUTICS | 5 | 6 | 0,00 % | ||
| ABCELLERA BIOLOGICS | 4 | 1 | +0,92 % | ||
| PACIFIC BIOSCIENCES OF CALIFORNIA | 3 | 3 | +3,31 % | ||
| TANGO THERAPEUTICS | 3 | 3 | 0,00 % | ||
| ZAI LAB LTD ADR | 2 | 6 | -1,53 % | ||
| APELLIS PHARMACEUTICALS | 2 | 4 | -0,72 % | ||
| WAVE LIFE SCIENCES | 2 | 2 | +2,42 % | ||
| LEGEND BIOTECH | 2 | - | -0,57 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 10:46 | Boehringer Ingelheim and Zai Lab team up for dual DLL3 therapy study | 1 | Pharmaceutical Technology | ||
| 09:30 | Curevac im Blickpunkt: Warum Insider bereits reagiert haben - Meine klare Einschätzung dazu | Hebelschein-Spekulant | |||
| 08:22 | MESOBLAST LIMITED: Appendix 3Y for Gregory George | - | ASX | ||
| 08:17 | DKSH erhält Aufträge von Yeastup und Sanofi | 4 | cash | ||
| 08:13 | MESOBLAST LIMITED: Notification of cessation of securities - MSB | - | ASX | ||
| 08:09 | MESOBLAST LIMITED: Notification regarding unquoted securities - MSB | - | ASX | ||
| 08:05 | MESOBLAST LIMITED: Application for quotation of securities - MSB | - | ASX | ||
| 08:03 | MESOBLAST LIMITED: Notification regarding unquoted securities - MSB | - | ASX | ||
| 05:05 | Down almost 20% this year, how high could Mesoblast shares go? | 2 | The Motley Fool Australia | ||
| 04:26 | Tempus AI (TEM) Unveils Cancer Test Kit, Soars 13.9% | 17 | Insider Monkey | ||
| Mi | $1000 Invested In Amgen 15 Years Ago Would Be Worth This Much Today | 5 | Benzinga.com | ||
| Mi | Wave Life Sciences plans redomicile from Singapore to U.S. | 4 | Investing.com | ||
| Mi | Adaptive Biotechnologies to Report First Quarter 2026 Financial Results on May 5, 2026 | 2 | GlobeNewswire (USA) | ||
| Mi | Royalty Pharma plc: Royalty Pharma to Announce First Quarter 2026 Financial Results on May 6, 2026 | 2 | GlobeNewswire (USA) | ||
| Mi | Recursion-CEO erläutert KI-Strategie zur Beschleunigung der Medikamentenentwicklung | 4 | Investing.com Deutsch | ||
| Mi | Roivant Sciences (ROIV): A Clinical Trial Win Meets a Phase 3 Failure | 5 | Insider Monkey | ||
| Mi | Wave Life Sciences Ltd. - 8-K, Current Report | - | SEC Filings | ||
| Mi | Eton Pharmaceuticals, Inc. - 8-K, Current Report | - | SEC Filings | ||
| Mi | ADMA Crashes 42.5% YTD: Right Time to Buy the Stock? | 3 | Zacks | ||
| Mi | Gilead widens global Yeztugo access agreement, but MSF says supply is 'not nearly enough' | 15 | FiercePharma |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.